Chad C. Henderson is a recognized thought leader in the healthcare real estate industry and has been a successful, serial entrepreneur for over 15 years allowing him to interact with a variety of leading healthcare executives and leaders nationwide. Chad is the Co-Founder and Chief Executive Officer (CEO) of Catalyst CRE – A THG Investments Company. He has led Catalyst CRE in guiding hospitals, integrated healthcare systems, and specialty providers of all sizes in planning, creating, optimizing, and maintaining their healthcare real estate assets. Currently, Catalyst CRE has ongoing development and acquisition activity of healthcare facilities throughout the Southeast and Midwest United States. Catalyst CRE also provides healthcare real estate leasing, property, and facility services to over 150 locations throughout 8 states.
Prior to launching Catalyst CRE, Chad founded THG Investments, a private investment firm with a focus of providing capital and management services to opportunities in healthcare real estate and healthcare niche operating companies. In addition to Catalyst CRE, THG Investments also launched and now manages Intelligent Retinal Imaging Systems (IRIS), a retinal screening company focused on ending preventable blindness. IRIS has operations in over 15 states and has successfully screened over 50,000 patients. Chad serves on IRIS’s Board of Directors.
Chad possesses a Bachelor of Science in Finance from Florida State University. Chad and his wife, Brooke, have been married for 10 years and have two sons: Charlie and Archie, who both never seem to run out of energy.